Revolutionary Findings: Statins May Save Lives in Sepsis Cases
A study suggests that statins, drugs lowering bad cholesterol, potentially reduce sepsis-related death rates by nearly 40%. Used initially against cardiovascular diseases, statins show promise in treating inflammations. Researchers call for clinical trials to validate effects on critically ill sepsis patients, highlighting significantly lower ICU and in-hospital mortality rates.
- Country:
- India
In groundbreaking research, statins have been shown to potentially reduce the death rate by almost 40% for critically ill patients suffering from sepsis. This revelation comes from a study published in Frontiers in Immunology, highlighting the promising role these cholesterol-lowering drugs could play in severe infections.
Sepsis, which triggers an extreme immune response leading to possible organ damage, remains life-threatening. Statins, typically used to combat cardiovascular diseases, are now under scrutiny for their anti-inflammatory properties and potential to mitigate excessive inflammatory responses while showing potential antimicrobial actions.
The extensive study reviewed medical records from Beth Israel Deaconess Medical Center, examining over 265,000 adult sepsis patients and found that those treated with statins had significantly reduced mortality rates. Researchers urge further trials to confirm these promising findings, which could shift how sepsis is treated globally.
(With inputs from agencies.)
Google News